Abbott vs Amgen (ABT vs AMGN)

Abbott (ABT) vs Amgen (AMGN) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

Abbott (ABT) and Amgen (AMGN) compete in healthcare and pharma. Here are Abbott and Amgen side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Abbott or Amgen.

Abbott vs Amgen: the figures

Abbott and Amgen figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Abbott or Amgen figure is not available, and we never estimate it.

3 key differences between Abbott and Amgen

1. Profitability: for every 100 of sales, Amgen keeps 23.0 as net profit and Abbott keeps 9.7.
2. Valuation: Abbott trades at 42.9x its annual earnings and Amgen at 29.7x; the market pays more for each dollar of Abbott profit, usually because it expects more growth.
3. Growth: Abbott grew sales +14.5% year on year in its latest quarter, against +9.5% for Amgen.

Abbott or Amgen: which fits your profile

• If you want growth: Abbott is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
• If you want income (dividends): Abbott pays the higher dividend relative to its price.
• If you prefer caution: Abbott has less debt relative to its profit, which usually gives more room in a bad year.
• If price is what matters most to you: Amgen trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.

Neither Abbott nor Amgen wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How Abbott and Amgen make money

Abbott (ABT)

Abbott reports four segments: Medical Devices, the largest, including FreeStyle Libre glucose sensors and heart devices; Diagnostics, selling lab analyzers and tests; Nutrition, with Similac, PediaSure and Ensure; and Established Pharmaceuticals, branded generic drugs sold in emerging markets. It operates in the U.S. and internationally. Full Abbott analysis.

Amgen (AMGN)

Amgen is a biotech that sells branded medicines such as Repatha for cholesterol, Prolia and Evenity for bone health, Enbrel and Tezspire for inflammation, and Tepezza and Krystexxa for rare diseases, along with biosimilars. It reports a single segment, and the United States accounts for most of its sales. Full Amgen analysis.

Frequently asked questions: Abbott vs Amgen

Is Abbott or Amgen the better stock?

Choosing between Abbott and Amgen depends on what you are looking for. Abbott is growing faster right now, and Amgen trades on the lower P/E. Fintols does not tell you whether to buy Abbott or Amgen: it shows you the differences so you can decide.

Which pays a higher dividend, Abbott or Amgen?

As of November 4, 2026, Abbott yields 2.30% and Amgen yields 2.19%. Also check how much of their profit Abbott and Amgen pay out: if it is more than they earn, it cannot last.

Which is more expensive, Abbott or Amgen?

On P/E, Abbott (42.9x) is more expensive than Amgen (29.7x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both Abbott and Amgen?

Yes. Many people spread their money across several companies, such as Abbott and Amgen, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Abbott or Amgen.

More comparisons with Abbott or Amgen

• AbbVie vs Abbott
• Abbott vs Eli Lilly
• AbbVie vs Amgen
• Amgen vs Eli Lilly

More companies like Abbott and Amgen: healthcare and pharma stocks. Educational content about Abbott and Amgen, not investment advice.